Clinical Trial Update: Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating maintenance therapy with apatinib after chemoradiotherapy in metastatic nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Nasopharyngeal Neoplasms | Phase 2 | Status: COMPLETED